Description
Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today's clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address both the foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.- Discusses cutting-edge therapeutic approaches to the medical care of cardiology patients with diabetes, combining coverage of the latest understanding of the complex relationship between diabetes and cardiovascular disease with recent clinical advances.- Offers a contemporary, clinical focus based on a new understanding of underlying pathologies, as well as application of evidence from clinical trials that have dramatically changed treatment and affected both cardiology and endocrinology practice.- Includes state-of-the-art coverage of antihyperglycemic medications that have demonstrated efficacy to reduce risk for atherosclerotic cardiovascular disease, heart failure, and kidney disease progression, that have affected a revolution of therapy in both cardiology and endocrinology.- Features a practical, concise presentation with a focus on actionable clinical content, including new Clinical Practice Points and Take Home Summaries.- Any additional digital ancillary content may publish up to 6 weeks following the publication date.
Table of Contents
PART I DIABETES MELLITUS1 Definition and Epidemiology of Type 2 Diabetes Mellitus2 Insulin Resistance: Pathophysiology, Molecular Mechanisms, and Genetic Insights3 Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus4 Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes5 Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and DiseasePART II CARDIOVASCULAR COMPLICATIONS OF TYPE 2 DIABETES6 Epidemiology of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease7 Pathology and Vascular Biology of Atherosclerosis in Patients With Type 2 Diabetes8 Risk Stratification Among Patients With Type 2 Diabetes With or at Risk for Atherosclerotic Cardiovascular Disease9 Epidemiology and Pathophysiology of Heart Failure With Preserved and With Reduced Ejection Fraction in Patients With Type 2 DiabetesPART III EFFECTS OF ANTIHYPERGLYCEMIC THERAPIES FOR TYPE 2 DIABETES ON CARDIOVASCULAR AND KIDNEY OUTCOMES10 Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes11 Regulatory Approach to Medications for Type 2 Diabetes: Past, Present, and Future12 Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors13 Cardiovascular and Kidney Effects of Glucagon-Like Peptide 1 Receptor Agonists14 Antihyperglycemic Medications With Proven Cardiovascular Safety15 Prevention of Heart Failure in People With Diabetes16 Treatment of Patients With Reduced and With Preserved Ejection Fraction Heart Failure in Patients With Type 2 DiabetesPART IV MANAGEMENT OF CORONARY HEART DISEASE RISK CHRONIC AND ACUTE CORONARY SYNDROMES IN PATIENTS WITH TYPE 2 DIABETES17 Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients With Type 2 Diabetes18 Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes19 Effect of Lipid Management on Coronary Heart Disease Risk in Persons With Type 2 Diabetes20 Effect of Antithrombotic Therapy on Coronary Heart Disease Risk in People With Diabetes Mellitus21 Role of Percutaneous Coronary Intervention in Patients With DiabetesPART V OTHER CARDIOVASCULAR CONSIDERATIONS FOR PATIENTS WITH TYPE 2 DIABETES22 Peripheral Artery Disease in Persons With Type 2 Diabetes23 Cerebrovascular Disease in Persons With Diabetes24 Atrial Fibrillation in Persons With Type 2 Diabetes25 Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients With Type 2 Diabetes26 Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Females, Racial/Ethnic Minorities, and the Elderly27 The Quality Chasm and the Need for Implementation Science to Reduce Cardiovascular Disease Risk in Type 2 Diabetes
